Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2006 by Samaritan Pharmaceuticals, Inc.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Samaritan Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00113412
First received: June 7, 2005
Last updated: March 21, 2006
Last verified: March 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given